Prudential Financial Inc Anavex Life Sciences Corp. Transaction History

Prudential Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$8.9 - $12.86 $338,022 - $488,422	37,980 New	37,980 $391,000
Q2 2022 Aug 15, 2022	SELL	$7.31 - $12.84 $714,771 - $1.26 Million	-97,780 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$9.74 - $17.69 $193,826 - $352,031	19,900 Added 25.55%	97,780 $1.2 Million
Q4 2021 Feb 14, 2022	BUY	$16.88 - $23.31 $1.31 Million - $1.82 Million	77,880 New	77,880 $1.35 Million

159

31.6M

910K

1.35M

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $352M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.